Oculis Holding AG (OCS) Shares Outstanding (Weighted Average) (2021 - 2026)

Oculis Holding AG (OCS) recorded quarterly Shares Outstanding (Weighted Average) of $739.7 million in Q1 2026, up 7.15% quarter-over-quarter from $690.3 million in Q4 2025, and up 43.26% on a YoY basis from $516.3 million in Q1 2025.

Oculis Holding AG (OCS) Shares Outstanding (Weighted Average) (2021 - 2026) Analysis & Trends

Oculis Holding AG's Shares Outstanding (Weighted Average) history runs 6 years deep, the most recent figure standing at $739.7 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) rose 43.26% year-over-year to $739.7 million; the TTM figure through Mar 2026 stood at $739.7 million (up 43.26% YoY), while the FY2025 annual figure was $690.3 million, up 75.31% from the prior year.
  • Shares Outstanding (Weighted Average) was $739.7 million for Q1 2026 at Oculis Holding AG, up from $690.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $739.7 million in Q1 2026 to a low of $4.0 million in Q4 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $408.4 million across 5 years, with a median of $393.5 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) jumped 3360.76% in 2022, then grew 20.57% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $4.0 million in 2022, then jumped by 921.99% to $41.3 million in 2023, then soared by 853.03% to $393.8 million in 2024, then soared by 75.31% to $690.3 million in 2025, then advanced by 7.15% to $739.7 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $739.7 million (Q1 2026), $690.3 million (Q4 2025), and $583.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 185,491.37 Bn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 4,489.46 Bn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 118.76 Bn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 417.01 Bn
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 254.10 Mn
9 Abivax 90.15 Bn 90.15 Bn - 928.40 Mn
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 739.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 739.66 Mn
Dec 31, 2025 690.31 Mn
Sep 30, 2025 583.62 Mn
Jun 30, 2025 563.41 Mn
Mar 31, 2025 516.30 Mn
Dec 31, 2024 393.76 Mn
Sep 30, 2024 393.17 Mn
Mar 31, 2024 330.40 Mn
Dec 31, 2023 41.32 Mn
Sep 30, 2023 326.09 Mn
Jun 30, 2023 318.86 Mn
Dec 31, 2022 4.04 Mn
Dec 31, 2021 -123,983.53